Gynaecological surgery. Introduction. MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c

Size: px
Start display at page:

Download "Gynaecological surgery. Introduction. MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c"

Transcription

1 DOI: / Gynaecological surgery Large loop versus straight-wire excision of the transformation zone for treatment of cervical intraepithelial neoplasia: a randomised controlled trial of electrosurgical techniques MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c a Fernandes Figueira Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil b National Institute of Quality Control in Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil c Walter Prendiville, International Agency for Research on Cancer, World Health Organization, Lyon, France Correspondence: MJ Camargo, Fernandes Figueira Institute, Oswaldo Cruz Foundation, Rio de Janeiro , Brazil. mariaj. camargo@hotmail.com Accepted 13 October Published Online 17 December Objective To compare two electrosurgical techniques, straight-wire excision of transformation zone (SWETZ) with large loop excision of transformation zone, as a cone procedure (LLETZ-cone), for the treatment of cervical intraepithelial neoplasia (CIN), when disease is present at the cervical canal. Design Randomised controlled trial. Setting Two public hospitals, one in Rio de Janeiro, Brazil and one in Dublin, Ireland. Population One hundred and three women with indication to treat CIN located at cervical canal. Methods Women were randomised to receive LLETZ-cone or SWETZ. Outcomes Main outcome was the incidence of complete excision of disease at endocervical margin of the surgical specimen. Secondary outcomes were complete excision at ectocervical and stromal margins, time to complete the procedure, specimen fragmentation, blood loss and death after 1 year. Results Fifty-two women were allocated to LLETZ-cone and 51 to SWETZ. Ten women were lost for main outcome because of damaged specimens. Forty-two women in the LLETZ-cone group had free endocervical margin versus 43 women in the SWETZ group (relative risk 1.04, 95% confidence interval [95% CI] ; P = 0.64). For secondary outcomes related to margins, we observed a relative risk of 1.15 (95% CI ; P = 0.15) for ectocervical free margin. For free stromal margin, the relative risk was 1.07 (95% CI ; P = 0.47). No death was observed. Conclusions This study was inconclusive; SWETZ and LLETZcone were equally effective to treat endocervical disease, with no difference in protecting against margin involvement. Higher, but not severe, blood loss and longer surgical time were observed in the SWETZ group. Keywords Cervical intraepithelial neoplasia, cervix dysplasia, cone biopsy, electrosurgery, treatment margins. Please cite this paper as: Camargo MJ, Russomano FB, Trist~ao MA, Huf G, Prendiville W. Large loop versus straight-wire excision of the transformation zone for treatment of cervical intraepithelial neoplasia: a randomised controlled trial of electrosurgical techniques. BJOG 2015;122: Introduction With new cases every year, cervical cancer was the fourth most common cancer affecting women worldwide in There were estimated deaths from cervical cancer in 2012, accounting for 7.5% of all female cancer Trial registration: ClinicalTrials.gov. NCT (Diathermy cone biopsy: a study of two techniques) deaths. Almost 87% of those deaths occur in underdeveloped regions. 1 In Brazil, new cases of cervical cancers are expected in Organised screening programmes followed by treatment of screen-positive women are associated with a dramatic reduction in deaths. Large loop excision of transformation zone (LLETZ) is a commonly used treatment for cervical intraepithelial neoplasia (CIN) and its popularity is the result of a number of advantages that include ease of technique, outpatient set- 552 ª 2014 Royal College of Obstetricians and Gynaecologists

2 LLETZ-cone versus SWETZ for the treatment of CIN ting, histological analysis of the specimen and low cost. 3 However, for endocervical pre-invasive disease LLETZ is not always adequately performed. There is relatively little information on this form of treatment of CIN, particularly on women with a type 3 transformation zone or glandular disease. The excision, in different degrees of depth at the cervix canal, may not completely remove the disease. Endocervical CIN demands a different approach, a cone biopsy classified as type three excision. 4 The usual method uses LLETZ with the objective of achieving 20-mm depth at the endocervical canal. Another technique, straight-wire excision of transformation zone (SWETZ), is a method of electrosurgically excising the endocervical transformation zone or glandular disease, using a 1-cm straight-wire electrode. The activated wire is used in the same way as a cold knife, fashioning a cone biopsy. 5 It has also been described as needle excision of the transformation zone (NETZ). 6 A systematic review evaluating surgery for CIN included many types of interventions, and concluded that there was no obviously superior surgical technique for treating CIN. 7 Two randomised trials were described in this review comparing NETZ with LLETZ. Panoskaltsis et al. 8 indicated better performance of NETZ in terms of specimen fragmentation, free margins and risk of residual disease. We did not find any randomised trial comparing these techniques to treat women with endocervical disease. Incomplete excision exposes women to a substantial risk of high-grade post-treatment disease, especially if deep margins are involved The objective of this study was to compare these techniques in terms of achieving free margins of disease for the treatment of women with a type 3 transformation zone or glandular disease. Papanicolaou smear presenting high-grade squamous intraepithelial lesion (HSIL) in an incomplete visible transformation zone, suspicion of microinvasive or invasive carcinoma and suspicion of glandular disease. Ectocervical premalignant condition has not been considered an indication for cone biopsy. Patients were excluded from the trial if they presented only ectocervical disease (type one or two transformation zone), coagulation disorders, cervicitis, pregnancy or refusal to participate in the study. Interventions The standard procedure, LLETZ-cone, was performed with a large loop electrode of 2-cm depth. The activated loop was applied to the cervix outside the lateral margin of the transformation zone and brought slowly to the contralateral margin with the ambition of removing a 2-cm length of endocervical epithelium, using a blend two coagulation setting of W (Figure 1) SWETZ uses a 1-cm straight, 0.2-cm wire electrode, to fashion a 2-cm excision, using a blend two coagulation setting of 40 W (Figure 2). After excision, the biopsy specimen was opened and pinned to a cord or polystyrene pad before immersion in formalin, thereby facilitating serial section histology. Three surgeons, two in Rio de Janeiro and one in Dublin, participated in the study. All of them were colposcopists and trained in both techniques. Some medical residents had also operated women, under supervision. The procedures were under- Methods Design and setting This was an open randomised trial with two participating public hospitals: Instituto Fernandes Figueira at Oswaldo Cruz Foundation (IFF/Fiocruz) in Rio de Janeiro, Brazil and Coombe Women & Infants University Hospital, in Dublin, Ireland. Both hospitals provide medical assistance for women requiring maternity, neonatal and gynaecology care and are leading institutions in healthcare research, education and training. Participants At IFF/Fiocruz, since 1999 every woman with premalignant cervical disease and indication for a cone biopsy has been submitted to electrosurgical conisation. From this cohort of women, people were recruited to take part in the trial. Patients were eligible if they presented endocervical disease (type 3 transformation zone or suspicion of glandular disease). Common indications for a cone biopsy included: Figure 1. LLETZ-cone technique. 3 ª 2014 Royal College of Obstetricians and Gynaecologists 553

3 Camargo et al. concealment. Once selected to trial entry, the name of the woman was written on the envelope and it was opened just before the procedure. This constituted trial entry. If for any reason the procedure was not performed, the woman remained in the study and the envelope was returned to the trial coordinator. Sample size According to the analysis of the cohort of women usually submitted to cone biopsy in our colposcopy clinic, LLETZcone is associated with approximately 80% rate of complete endocervical margin excision. We thought that an increase of 15% of complete excision might influence clinicians to consider changing techniques, if this difference was achieved by SWETZ. One hundred and forty-six women would be required to have an 80% chance of detecting an increase in the rate of complete endocervical margin excision, from 80% in the LLETZ-cone group to 95% in the SWETZ group, as significant at the 5% level. 12 Figure 2. SWETZ technique. 3 taken in the operating room and in most cases local anaesthesia plus sedation was used. Outcomes Our primary outcome was the proportion of women achieving complete excision of dysplasia at the endocervical margin, as recognised histologically in each group. The pathologist was blinded to the used technique. Secondary outcomes were perioperative and histological evaluations. Operative outcomes were: time to complete the procedure; fragmentation of the surgical specimen, assessed by the number of excised pieces; and blood loss. Procedure time was recorded from insertion until removal of the vaginal speculum. Blood loss was categorised according to surgeon s visual observations during the procedure as: <20 ml, between 20 and 100 ml and >100 ml, and was recorded just after the end of surgery. Mortality in 1 year was also assessed. Histological secondary outcomes were ectocervical and stromal margins free of disease. Randomisation The random allocation generation was generated centrally in the RCSI Department of Obstetrics and Gynaecology at the Coombe Women s Hospital using computer-generated random numbers. Randomisation was stratified for each centre. Consecutively numbered treatment options were placed in opaque, sealed envelopes to ensure allocation Data analyses We assessed the success of randomisation by comparing sociodemographic and clinical characteristics between the two treatment groups and calculated relative risks (with 95% confidence intervals [95% CI]) for primary and secondary outcomes using an intention-to-treat analysis. For continuous variables we used means, standard deviations and Student s t-test. Data were analysed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). Deviations from protocol The trial stopped early, before the estimated number of women was achieved. The reason was that the participation of some voluntary pathologists could not be maintained until the end of the study. Results Between November 1999 and December 2004, 127 women were assessed for eligibility and 103 were randomised, the majority in Rio de Janeiro, seven participants in Dublin. Five women refused to participate in the study and 19 did not meet the inclusion criteria (Figure 3). Fifty-two women were allocated to LLETZ-cone and fifty-one to SWETZ. For the primary outcome, data were available for 93 women (90.3%). Ten women had unknown margin status because of fragmentation of the specimen or thermal damage. They were analysed according to an intention-to-treat approach. There were no losses for perioperative outcomes, which include procedure time, blood loss and number of pieces. Clinical and sociodemographic characteristics of participants are described in Table 1. Patients in the two groups 554 ª 2014 Royal College of Obstetricians and Gynaecologists

4 LLETZ-cone versus SWETZ for the treatment of CIN Table 1. Characteristics of women by intervention group LLETZ-cone n = 52 SWETZ n = 51 Age (years), mean (SD) 45.6 (11.5) 43.7 (9.9) Parity, mean (SD) 3.3 (11.5) 3.1 (2.5) Papanicolaou smear CIGN 1 (1.9) 4 (7.8) LSIL 3 (5.8) 2 (3.9) HSIL 37 (71.2) 44 (86.3) Invasion 11 (21.2) 1 (2.0) Colposcopic diagnosis HSIL (major changes) 37 (71.2) 28 (54.9) LSIL (minor changes) 5 (9.6) 9 (17.6) Invasion 1 (1.9) Inconclusive/Unsatisfactory 9 (17.3) 14 (27.5) Cone indication AIS 1 (1.9) 2 (3.9) Recurrence 1 (1.9) Cancer suspicion 5 (9.6) 1 (2) TZ incompletely seen 43 (82.7) 47 (92.2) Others 2 (3.8) 1 (2) Length of the excision attempted (cm), mean (SD) 2.84 (0.79) 2.67 (0.69) Figure 3. Flow diagram of the study. Values are numbers (percentage) unless stated otherwise. AIS, adenocarcinoma in situ; CIGN, cervical intraepithelial glandular neoplasia; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; TZ, transformation zone. had similar baseline characteristics, except for cytological diagnosis. A Papanicolaou smear suggesting invasion was present in 11 of 52 women in the LLETZ-cone group compared with one woman of 51 in the SWETZ group. Most women enrolled in this study were in their fifth decade, with a medium parity of three and with high-grade disease; the transformation zone being incompletely seen was the main indication for surgery. For the primary outcome (Table 2), 80.8% of women in the LLETZ-cone group were reported as having an endocervical margin that was free of disease compared with 84.3% of women in the SWETZ group. The relative risk for complete excision was 1.04 (95% CI ; P = 0.64). For secondary outcomes related to margins, we observed a relative risk of 1.15 (95% CI ; P = 0.15) for ectocervical margin free of disease. For stromal margin, the relative risk of a free margin was 1.07 (95% CI ; P = 0.47). No statistical significance was observed for incomplete excision at any margin for women with endocervical disease. When perioperative outcomes were analysed, the surgical time was significantly longer for women submitted to SWETZ, with a mean of 23.2 minutes (SD 8.1), compared with LLETZ-cone (mean 13.5 minutes; SD 5.3), difference of means 9.7 ( ; P = 0.000). The fragmentation of the specimen during the excision was more frequent in the LLETZ-cone group than in the SWETZ group, with 86% of women having the excision performed in one fragment by LLETZ-cone compared with 96% by SWETZ. The relative risk was 1.11 (95% CI ; P = 0.09). The blood loss was small for both groups, only one woman lost >100 ml in the LLETZ-cone group; but surgical bleeding was clinically and statistically greater in the SWETZ group. Five women (5.7%) in the LLETZ-cone group lost between 20 and 100 ml of blood and 14 women (27.4%) submitted to SWETZ lost the same amount of blood. Nobody had died by 1 year after the procedure. The definitive histological diagnosis is presented in Table 3, and there were no important differences between groups. Overall, eight women had no disease, 15 had lowgrade disease (CIN 1, HPV), 72 had high-grade disease (CIN 2 3, AIS), two had microinvasive disease and four had invasive cancer. Discussion Main findings Both surgical procedures were effective in achieving clear histological margins, with complete excision ranging from ª 2014 Royal College of Obstetricians and Gynaecologists 555

5 Camargo et al. Table 2. Histological and operatives outcomes Patients outcomes Free endocervical margin (primary outcome) Free ectocervical margin Free stromal margin Procedure time in minutes (SD) Specimen not fragmented Blood loss <20 ml LLETZ-cone n = 52 SWETZ n = 51 Relative risk (CI) P-value 42 (80.8) 43 (84.3) 1.04 ( ) (75.0) 44 (86.3) 1.15 ( ) (78.8) 43 (84.3) 1.07 ( ) (5.3) 23.2 (8.1) 9.7 ( )* (86) 49 (96) 1.11 ( ) (88.5) 36 (71) 0.80 ( ) 0.03 Values are numbers (percentages) unless stated otherwise. *Difference of means. Table 3. Definitive histological diagnosis LLETZ-cone n = 52 SWETZ n = 51 Adenocarcinoma 1 (2) AIS 1 (1.9) 2 (3.9) CIN (not specified) 1 (3.9) HSIL (CIN2, CIN3) 35 (67.3) 33 (64.7) LSIL (HPV, CIN1) 6 (11.5) 9 (17.6) Squamous carcinoma 2 (3.8) 1 (2) Microinvasive carcinoma 2 (3.8) Negative 5 (9.6) 3 (5.9) Not stated 1 (1.9) 1 (2) Values are numbers (percentages). AIS, adenocarcinoma in situ; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion. 75% to 86%, with no statistical difference between the two techniques. There was no statistically significant difference concerning surgical fragmentation, an important issue when it comes to the diagnosis of microinvasive disease. Statistical significance was obtained for procedure time and blood loss. SWETZ demanded longer surgical time (23.2 minutes versus 13.5 minutes), which reflects the complexity of the procedure with the need to fashion the cone using the straight wire. This could also suggest that not all the colposcopists involved were familiar with the technique. Both procedures took longer than reported in the literature. 6,8 Women in the SWETZ group were significantly at greater risk of bleeding, even so, only four women in both groups combined had >100 ml blood loss, all solved during surgery with hemostatic sutures. Strengths and limitations This study was planned to be conducted with minimal funding, little or no interference in the routine of the service and voluntary collaboration. Unfortunately, an important part of these volunteers had to leave the hospital when approximately 70% of women had been included. Stopping the trial before achieving the necessary number of participants was a drawback, probably influencing the statistical significance for most outcomes. Nevertheless, to our knowledge, this was the first study to evaluate electrosurgical excision procedures for women with transformation zone type 3 or glandular disease. Consequently, the main strength of our study is to select only those women with endocervical disease and to choose the appropriate devices for an adequate depth of excision (a loop with 2-cm depth and a 1-cm straight wire used to achieve 2-cm depth). Losses for the primary outcome were minimal, about 10%, because of limitation of electrosurgical techniques, such as thermal damage and fragmentation. For perioperative outcomes no loss of follow-up was observed. The concealment of allocation and the blinded rating of the main outcome are other strengths of this study. Interpretations Incomplete excision of CIN increases the risk of post-treatment high-grade disease six-fold; 9 therefore, every effort to avoid incomplete excision should be welcome. There were some reasons for the inconclusive results, such as stopping the study earlier or anticipating a bigger difference between the two groups than what was actually found. We based our assumptions on literature reports, finding 12 27% differences favouring needle excision for margin protection. 8,13 LLETZ is usually performed in a flexible way, allowing different depths of loop, but NETZ is normally performed in a more standardised way; 6,8,13 to establish a standardiasation of these devices could be a way to enhance the treatment of women with pre-invasive endocervical disease. Most of the randomised studies evaluating electrosurgical procedures for CIN treatment do not distinguish women with ectocervical and endocervical dysplasia. In the trial by Panoskaltsis et al., 404 women were included with only 29 women treated for endocervical disease and it was not possible to access the number of women under the same conditions in the studies by Sadek and by Basu et al. 6,13 The major implication for this lack of selection criteria in many studies is that it enhances 556 ª 2014 Royal College of Obstetricians and Gynaecologists

6 LLETZ-cone versus SWETZ for the treatment of CIN the possibility of undertreating those women with dysplastic epithelium that is not accessible by colposcopy. The differences in endocervical margins are small (4%) and might be related to different degrees of surgeon s experience with the new technique. One of the main criticisms of eletrosurgical excisional procedures is the impact on women s reproductive life, but if a straight selective criterion is applied, and the endocervical disease is focused, only the oldest women will be submitted to more extensive excision such as cone biopsy: in our study, the average age was 44.6 years. We believe that the lack of a good screening programme in Brazil could raise the prevalence of pre-invasive disease in older women, compared with developed countries with better screening programmes the low number of women recruited in Dublin could reflect this reality. We understand that the presence of disease during the follow up provides better evaluation of therapeutic success. In this study we could not access this information and future studies should focus on cytological follow-up results after LLETZ/SWETZ. Because there are no long-term followup data is it not possible to demonstrate if the two techniques have different cure rates. Conclusion SWETZ and LLETZ-cone were both effective in achieving clear histological margins with no statistical difference between the two techniques. There was, however, higher but not severe blood loss and longer performance time for SWETZ compared with LLETZ-cone. Further studies focused on the treatment of women with CIN located at the cervical canal including follow-up results are needed to improve therapeutic success. Disclosure of interest The authors declared no conflicts of interest. Contribution to authorship WP conceived and designed the experiments. MJC was the principle investigator, searched for publications, wrote the original protocol with WP, and performed the experiments in cooperation with FR, WP and MAT. FR designed the database. GH and FR performed the analysis. MJC and GH wrote the paper. Details of ethics approval The study protocol was approved by Ethics Committees in Brazil (CONEP: 552/99) and Ireland (Coombe Women s Hospital MT/ff 17 October 1997). Funding The authors received no funding for this study. All funding was intramural. Acknowledgements We would like to thank Dr Aldo F F Reis, Dr Maria Jose Maisonette, Dr Fernanda Borzino and Dr Nathalie Raibolt for their help with this study. & References 1 Cervical cancer. Estimated incidence, mortality and prevalence worldwide in [ cervix-new.asp]. Accessed 21 April Cancer Incidence in Brazil. Rio de Janeiro: INCA, [ Accessed 21 April Prendiville W. LLETZ. Theoretical rationale, practical aspects, clinical experience, optimizing the technique. In: Prendiville W (ed) Colposcopy: Management Options, London: Elsevier limited; p IFCPC Nomenclature. [ nomenclature]. Accessed 15 June Prendiville W. Large loop excision of the transformation zone. In: Prendiville W (ed) Large Loop Excision of the Transformation Zone: A Practical Guide to LLETZ; London: Chapman and Hall; p Sadek AL. Needle excision of the transformation zone: a new method of treatment of cervical intraepithelial neoplasia. Am J Obstet Gynecol 2000;182: Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO, Keep SL. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2010:CD Panoskaltsis T, Ind TE, Perryman K, Dina R, Abrahams Y, Soutter WP. Needle versus loop diathermy excision of the transformation zone for the treatment of cervical intraepithelial neoplasia: a randomized controlled trial. BJOG 2004;111: Ghaem-Maghami S, Sagi S, Majeed G, Soutter WP. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncol 2007;8: Gardeil F, Barry-Walsh C, Prendiville W, Clinch J, Turner MJ. Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol 1997;89: Oliveira CA, Russomano FB, Gomes Junior SCS, Corr^ea FM. Risk of persistent high-grade squamous intraepithelial lesion after electrosurgical excisional treatment with positive margins: a metaanalysis. Sao Paulo Med J 2012;130: Herbert R. Confidence interval calculator. [ direct.org/applied_statistics/binomial_distribution/ref/cicalculator.xls]. Accessed 15 December Basu PS, D Arcy T, McIndoe A, Soutter WP. Is needle diathermy excision of the transformation zone a better treatment for cervical intraepithelial neoplasia than large loop excision? Lancet 1999;353: ª 2014 Royal College of Obstetricians and Gynaecologists 557

What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester

What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester Qu. What is being excised? A. Colposcopic lesions which should contain CIN2+ Qu. Why is

More information

Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus

Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus University of Groningen Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman? Treatment of Cervical Intraepithelial Neoplasia Karen Smith-McCune Professor, Department of Obstetrics, Gynecology and Reproductive Sciences I have no conflicts of interest Case How would you manage this

More information

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates

More information

Management of Abnormal Cervical Cytology and Histology

Management of Abnormal Cervical Cytology and Histology Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline

More information

Cryotherapy has No Place in Colposcopy Practice

Cryotherapy has No Place in Colposcopy Practice Cryotherapy has No Place in Colposcopy Practice No financial disclosures No conflicts of interest ? Precision? Personalized Medicine? Best Evidence Based Practice Prinicipals of Surgical Management CIN1

More information

Understanding Your Pap Test Results

Understanding Your Pap Test Results Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities

More information

Efficacy of cervical intrarepithelial neoplasia (CIN)

Efficacy of cervical intrarepithelial neoplasia (CIN) The Ulster Medical Journal, Volume 72, No. 1, pp. 10-15, May 2003. Efficacy of cervical intrarepithelial neoplasia (CIN) treatment by cold coagulation A Zawislak, J H Price, H R McClelland, R G N Storey,

More information

Cervical Conization. 1

Cervical Conization.   1 Cervical Conization www.zohrehyousefi.com 1 Cone Biopsy is a surgical procedure with removal of a cone shaped portion of the cervix The extent of involvement of epithelium on the ectocervix has been clearly

More information

The treatment of CIN: what are the risks?

The treatment of CIN: what are the risks? REVIEW ARTICLE DOI:10.1111/j.1365-2303.2009.00669.x The treatment of CIN: what are the risks? Royal College of Surgeons in Ireland, Department of Gynaecology, Coombe and Tallagh Hospital, Dublin, Ireland

More information

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health

More information

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy The routine use of ZedScan within one colposcopy service in England MC Macdonald, R Lyon, JE Palmer, JA Tidy Introduction Colposcopic impression alone has been shown to be subjective with variable rates

More information

Colposcopy. Attila L Major, MD, PhD

Colposcopy. Attila L Major, MD, PhD Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000

More information

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in

More information

Management that provides continuity of care for women

Management that provides continuity of care for women Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred

More information

LEEP in the Family Practice Setting

LEEP in the Family Practice Setting LEEP in the Family Practice Setting David J. Lyman, MD, MPH, and Brent Morris Background: We wanted to review our 7-year experience using the loop electrical excision procedure (LEEP) for the treatment

More information

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

!#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ !"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years

Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years DOI: 10.1111/j.1471-0528.2008.01853.x www.blackwellpublishing.com/bjog Gynaecological oncology Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50

More information

Making Sense of Cervical Cancer Screening

Making Sense of Cervical Cancer Screening Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because

More information

Cuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015

Cuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015 Programme Report 2014/2015 Contents Summary points 2 Introduction to the statistics 2014/2015 3 Part 1 Cervical screening activity 3 Programme coverage 4 Laboratory turnaround time 7 Notification of results

More information

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy 1 Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy Julie Nelson Texas Woman s University Philosophy of

More information

CPC on Cervical Pathology

CPC on Cervical Pathology CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade

More information

This paper includes Author Insights, a video abstract available at

This paper includes Author Insights, a video abstract available at DOI: 10.1111/1471-0528.14808 www.bjog.org Epidemiology Risk of persistent or recurrent cervical neoplasia in patients with pure adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous

More information

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22 BJMP 2008:1(2) 18-22 Review Articl cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil Abbreviations BSCCP British Society of Colposcopy and Cervical Pathology CIN Cervical intraepithelial

More information

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim Is vaccination with quadrivalent HPV vaccine after Loop Electrosurgical Excision Procedure effective in preventing recurrence in patients with High-grade Cervical Intraepithelial Neoplasia (CIN2-3)? Chonnam

More information

Completeness of excision and follow up cytology in patients treated with loop excision biopsy

Completeness of excision and follow up cytology in patients treated with loop excision biopsy J Clin Pathol ;:9 9 9 Department of Pathology, Mayday University Hospital, London Road, Thornton Heath, Surrey CR7 7YE, UK A M Zaitoun M J Coppen S M Thomas Department of Pathology, The Royal Surrey County

More information

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Management Algorithms for Abnormal Cervical Cytology and Colposcopy Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent

More information

How invasive cervical cancer audit affects clinical practice

How invasive cervical cancer audit affects clinical practice How invasive cervical cancer audit affects clinical practice Referring to NHSCSP and EU guidelines and audits in Southampton and London Amanda Herbert Guy s & St Thomas Foundation NHS Trust How invasive

More information

Prof. Silvio Tatti MD, MSc, Phd, FACOG Past President IFCPC Hospital de Clínicas José de San Martín University of Buenos Aires

Prof. Silvio Tatti MD, MSc, Phd, FACOG Past President IFCPC Hospital de Clínicas José de San Martín University of Buenos Aires Prof. Silvio Tatti MD, MSc, Phd, FACOG Past President IFCPC Hospital de Clínicas José de San Martín University of Buenos Aires Introduction and Update of the new IFCPC nomenclature Professor Silvio Tatti

More information

The society for lower genital tract disorders since 1964.

The society for lower genital tract disorders since 1964. The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

Scottish Cervical Screening Programme. Colposcopy and Programme Management

Scottish Cervical Screening Programme. Colposcopy and Programme Management Scottish Cervical Screening Programme Colposcopy and Programme Management Addendum to NHSCSP Publication No 20 Second Edition Exceptions Applicable in NHS Scotland April 2013 (Final Version 2.8 to incorporate

More information

I have no financial interests in any product I will discuss today.

I have no financial interests in any product I will discuss today. Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics

More information

Eradicating Mortality from Cervical Cancer

Eradicating Mortality from Cervical Cancer Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus

More information

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) The cervix constitutes the lower third of the uterus. It is in two parts, the endocervix and the ectocervix. Ectocervix is covered with squamous epithelium. Endocervix

More information

International Federation of Gynecology and Obstetrics

International Federation of Gynecology and Obstetrics International Federation of Gynecology and Obstetrics Treatment of Cervical Precancerous Lesions using Thermocoagulation(Cold Coagulation) and Cryotherapy General Principles All high grade CIN should be

More information

Cervical Dysplasia and HPV

Cervical Dysplasia and HPV Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk

More information

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW Boureima Ali Nafissatou and Dong zhao * Department of Gynecology, Shanghai

More information

LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation

LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation Bridget Melley BSc. (Hons.) in Medical Science Galway-Mayo Institute

More information

What Causes Cervical Cancer? Symptoms of Cervical Cancer

What Causes Cervical Cancer? Symptoms of Cervical Cancer Cervical Health Awareness Month is a chance to raise awareness about how women can protect themselves from HPV (human papillomavirus) and cervical cancer. HPV is a very common infection that spreads through

More information

Chapter 10: Pap Test Results

Chapter 10: Pap Test Results Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the

More information

SOGC / SCC Clinical Practice Guideline

SOGC / SCC Clinical Practice Guideline SOGC / SCC Clinical Practice Guideline Colposcopic Management of Abnormal Cervical Cancer Screening and Histology These Clinical Practice Guidelines have been prepared and approved by the Executive and

More information

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%

More information

Int J Clin Exp Med 2015;8(2): /ISSN: /IJCEM Yan Chen, Jia-De Zhou

Int J Clin Exp Med 2015;8(2): /ISSN: /IJCEM Yan Chen, Jia-De Zhou Int J Clin Exp Med 2015;8(2):2447-2452 www.ijcem.com /ISSN:1940-5901/IJCEM0003911 Original Article Application value of different transformation zone types and its genetic relationship with high-risk HPV

More information

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D.

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. 27 May, 2014 London, England Faculty Disclosure X No, nothing to disclose Yes, please specify

More information

Investigation of 100 consecutive negative cone biopsies

Investigation of 100 consecutive negative cone biopsies British Journal of Obstetrics and Gynaecology January 1997, Vol. 104, pp. 100-104 Investigation of 100 consecutive negative cone biopsies *Pouran Golbang Research Fellow and Consultant (Gynaecology), **James

More information

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists HKCOG Guidelines Guidelines on the Management of An Abnormal Cervical Smear Number 3 revised November 2002 published by The Hong Kong College of Obstetricians and Gynaecologists A Foundation College of

More information

I have no financial interests to disclose.

I have no financial interests to disclose. Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests

More information

The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial

The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial DOI: 10.1111/j.1471-0528.2010.02519.x www.bjog.org Epidemiology The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial

More information

A comparative study of two methods of large loop excision of the transformation zone

A comparative study of two methods of large loop excision of the transformation zone BJOG: an International Journal of Obstetrics and Gynaecology April 2005, Vol. 112, pp. 490 494 DOI: 10.1111/j.1471-0528.2005.00427.x A comparative study of two methods of large loop excision of the transformation

More information

Becoming a colposcopist: Colposcope case studies

Becoming a colposcopist: Colposcope case studies Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening

More information

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016 GLANDULAR LESIONS PITFALLS IN MANAGEMENT Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016 Introduction Cervical glandular lesions are much less common than squamous lesion Incidence

More information

Your Colposcopy Visit

Your Colposcopy Visit Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to

More information

EARLY ONLINE RELEASE

EARLY ONLINE RELEASE EARLY ONLINE RELEASE Note: This article was posted on the Archives Web site as an Early Online Release. Early Online Release articles have been peer reviewed, copyedited, and reviewed by the authors. Additional

More information

National Cervical Screening Program MBS Item Descriptors

National Cervical Screening Program MBS Item Descriptors National Cervical Screening Program MBS Item Descriptors Item Item descriptor 73070 A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre-cancer

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 09/5/95 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

EFC and European Standards for Colposcopic Evaluation

EFC and European Standards for Colposcopic Evaluation EFC and European Standards for Colposcopic Evaluation Cagatay Taskiran, MD. Koc University School of Medicine, and VKF American Hospital Department of Obstetrics and Gynecology Division of Gynecologic

More information

Northern Ireland cervical screening programme. Information for primary care and smear takers

Northern Ireland cervical screening programme. Information for primary care and smear takers Northern Ireland cervical screening programme Information for primary care and smear takers From January 2011, the Northern Ireland cervical screening programme will no longer invite women aged under 25

More information

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Cervical Screening for Dysplasia and Cancer in Patients with HIV Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase

More information

Quality Evaluation of Cone Biopsy Specimens Obtained by Large Loop Excision of the Transformation Zone

Quality Evaluation of Cone Biopsy Specimens Obtained by Large Loop Excision of the Transformation Zone Elmer ress Original Article J Clin Med Res. 2015;7(4):220-224 Quality Evaluation of Cone Biopsy Specimens Obtained by Large Loop Excision of the Transformation Zone Aristoteles Mauricio Garcia Ramos a,

More information

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix DOI:10.31557/APJCP.2019.20.2.377 Cervical Screening Results Leading to Detecting Cervical AIS RESEARCH ARTICLE Editorial Process: Submission:09/27/2018 Acceptance:01/18/2019 Cervical Screening Results

More information

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila

More information

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa

More information

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN. CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee

More information

The implications of HPV immunisation on cervical screening

The implications of HPV immunisation on cervical screening The implications of HPV immunisation on cervical screening Dr Maggie Cruickshank Senior Lecturer in Gynaecology Scottish Cervical Cancer Prevention Programme (SCCPP) funded by CSO Cervical screening Detects

More information

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests www.treatmentok.com Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Ann Arbor, Michigan Disclosures

More information

The LAST Guidelines in Clinical Practice. Implementing Recommendations for p16 Use

The LAST Guidelines in Clinical Practice. Implementing Recommendations for p16 Use AJCP / Original Article The LAST Guidelines in Clinical Practice Implementing Recommendations for p16 Use Lani K. Clinton, MD, PhD, 1,2 Kyle Miyazaki, 1 Asia Ayabe, 1 James Davis, PhD, 2 Pamela Tauchi-Nishi,

More information

Gynaecological Pathology Reporting Cervical Pathology Dr Raji Ganesan Birmingham

Gynaecological Pathology Reporting Cervical Pathology Dr Raji Ganesan Birmingham Gynaecological Pathology Reporting Cervical Pathology Dr Raji Ganesan Birmingham Format Introduction Cervical biopsy Difficulties in diagnosis of CIN p16 Cervical loop Squamous carcinoma diagnosing and

More information

Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix

Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix Aust N Z J Obstet Gynaecol 2018; 58: 321 329 DOI: 10.1111/ajo.12753 ORIGINAL ARTICLE Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix Charlotte Paul

More information

Although rare, a significant increase in incidence

Although rare, a significant increase in incidence Original Research Concurrent Anal Human Papillomavirus and Abnormal Anal Cytology in Women With Known Cervical Dysplasia Jacqueline Lammé, MD, Tina Pattaratornkosohn, MD, Joselyn Mercado-Abadie, MD, Addie

More information

Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test(review)

Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test(review) Cochrane Database of Systematic Reviews Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test Kyrgiou M, Kalliala IEJ,

More information

Pap test results FOR WOMEN WITH AN ABNORMAL PAP TEST

Pap test results FOR WOMEN WITH AN ABNORMAL PAP TEST Pap test results FOR WOMEN WITH AN ABNORMAL PAP TEST Introduction This booklet provides women with information about abnormal Pap test results. Many women feel anxious or worried when they are told their

More information

Name of External Assessment Group (EAG) and project leads

Name of External Assessment Group (EAG) and project leads Title of the project Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: a systematic review and economic evaluation Name of External Assessment Group (EAG) and project leads

More information

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before

More information

Research & Reviews on. Cervical Cancer

Research & Reviews on. Cervical Cancer Chapter 5 Sandhya Babu Research & Reviews on Evidence Based Management of Cervical Precancer Consultant Obstetrician Gynaecologist, Wexford General Hospital, Ireland. Email: sandhya_ramesh95@yahoo.co.uk

More information

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0 / 0 / 6 ANY MISSING OR INCOMPLETE TEST RESULTS

More information

Proposed New Guidelines for the Management of Women with Abnormal Cervical Smears DRAFT FOR COMMENT

Proposed New Guidelines for the Management of Women with Abnormal Cervical Smears DRAFT FOR COMMENT Proposed New Guidelines for the Management of Women with Abnormal Cervical Smears DRAFT FOR COMMENT National Cervical Screening Programme National Screening Unit Ministry of Health October 2006 Table of

More information

Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation. K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen, J Steven, K Morton

Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation. K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen, J Steven, K Morton ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 5 Number 2 Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen,

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0/0/0 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med

More information

BC Cancer Cervix Screening 2015 Program Results. February 2018

BC Cancer Cervix Screening 2015 Program Results. February 2018 BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...

More information

HPV-related papillomatous-condylomatous lesions in female anogenital area

HPV-related papillomatous-condylomatous lesions in female anogenital area HPV-related papillomatous-condylomatous lesions in female anogenital area Theo Panoskaltsis MD, FRCOG, CCST (UK) Epidemiology Anal cancer is increasing in both men and women Groups at risk: - HIV (+)

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Vol 8 No ISSN 75 876 Findings and outcome of teenage women referred for colposcopy at Christchurch Women s Hospital, New Zealand Peter Sykes, Dianne Harker, David Peddie

More information

Histopathology: Cervical HPV and neoplasia

Histopathology: Cervical HPV and neoplasia Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about

More information

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z ,,,,, PATHOLOGY Q U I Z,,,,, PATHOLOGY QUIZ CASE HISTORY Alex Ferenczy, MD, Professor of Pathology and Obstetries and Gynaecology, The Sir Mortimer B. Davis ]ewish General HosPital, McGill University This

More information

EU guidelines for reporting gynaecological cytology

EU guidelines for reporting gynaecological cytology EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize

More information

Cervical Cancer : Pap smear

Cervical Cancer : Pap smear Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective

More information

Clinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages years

Clinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages years Clinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages 21-39 years Michelle I. Silver, PhD, ScM Cancer Prevention Fellow National Cancer Institute Division of Cancer

More information

ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust

ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust ZedScan Case Study NHS Hospital, UK. ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust Increased detection

More information

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health Cervical Cancer Screening Update Melissa Hartman, DO Women s Health Previous Cervical Cancer Screening Organization Recommendation ACS (2011) ACP (2008) NCI (2003) Age 21 or 3 years after first intercourse

More information

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases

More information

MICHELE FOLLEN MITCHELL, MD, MS, GUILLERMO TORTOLERO-LUNA, MD, PhD, ELISE COOK, MD, LORI WHITTAKER, MD, HELEN RHODES-MORRIS, MD, AND ELVIO SILVA, MD

MICHELE FOLLEN MITCHELL, MD, MS, GUILLERMO TORTOLERO-LUNA, MD, PhD, ELISE COOK, MD, LORI WHITTAKER, MD, HELEN RHODES-MORRIS, MD, AND ELVIO SILVA, MD Volume 92 November 1998 Number 5 A Randomized Clinical Trial of Cryotherapy, Laser Vaporization, and Loop Electrosurgical Excision for Treatment of Squamous Intraepithelial Lesions of the Cervix MICHELE

More information

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1 WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1 HOW TO CITE THIS ARTICLE: G. J. Vani Padmaja. Well Woman Clinic-Screening Program for Cervical Carcinomas. Journal of Evolution

More information

6 th EFC Satellite meeting, Saturday 1 st December 2018

6 th EFC Satellite meeting, Saturday 1 st December 2018 6 th EFC Satellite meeting, Saturday 1 st December 2018 Introduction Pekka Nieminen President-elect of the European Federation for Colposcopy, Department of Obstetrics and Gynaecology, Helsinki University

More information

Cytology Update M Laing QEUH

Cytology Update M Laing QEUH Cytology Update M Laing QEUH Age change to 25 to 65 Age 25 to 50 Three yearly smear invitation Age 50 to 65 Five yearly smear invitation Women on non routine screening will be invited up to age 70 OUTCOME

More information

Managament of Abnormal Cervical Cytology and Histology

Managament of Abnormal Cervical Cytology and Histology Managament of Abnormal Cervical Cytology and Histology Ali Ayhan, M.D Başkent University Faculty of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology Abnormal Cytologic

More information

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013 Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely

More information

ORIGINAL ARTICLES. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town. Methods

ORIGINAL ARTICLES. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town. Methods Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town Priya Batra, Louise Kuhn, Lynette Denny Objective. An audit of outcomes of cervical cancer screening

More information

Information on: Cervical. screening. (smear test) jostrust.org.uk

Information on: Cervical. screening. (smear test) jostrust.org.uk Information on: Cervical screening (smear test) jostrust.org.uk Cervical screening This booklet covers: What is cervical screening? Who is eligible for screening? What happens when I have a screening sample

More information

I have no financial interests in any product I will discuss today.

I have no financial interests in any product I will discuss today. Cervical Cancer Prevention: 2012 and Beyond George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University of California,

More information